Mergers and acquisitions – Page 16
-
Business
Evonik acquires US silicic acid ester supplier
German chemicals giant expand functional silane production in the US with Silbond purchase
-
BusinessMegamerger brings Actavis into R&D race
$25bn Forest Labs takeover will see generics giant take on patented products
-
BusinessGenerics give injectables a shot
A rash of recent acquisitions sees generics companies eager to enter speciality manufacturing market
-
Business
Merck & Co doubles up on Ablynx research deal
Cancer nanobody R&D partnership could be worth €1.7 billion
-
Business
Jazz spending spree has ups and downs
Aerial sells Jazz rights to sleeping sickness drug but Gentium shareholders put brakes on earlier deal
-
Business
Thermo Fisher to sell three analytical divisions to GE Healthcare
Deal will help the firm complete its ongoing takeover of Life Technologies
-
-
-
Business
Kemira now water-based after formic acid sale
Business sold to US agrichemical for €140 million
-
Business
AstraZeneca shells out $4.1bn for diabetes business
Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
-
Business
Merck KGaA snaps up electronic materials specialist
Firm looks to bolster R&D by acquiring AZ Electronic Materials
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
Business
DSM to spin out pharma unit
Firm will combine with Patheon to provide manufacturing services
-
BusinessRapid DNA sequencing cleared for the clinic
Illumina’s ‘next-generation’ MiSeqDx platform gets US approval
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
Business
Shire will cut UK R&D to focus on rare diseases
$4.2bn buyout of ViroPharma bolsters pipeline, while Basingstoke site halts research
-
Business
Solvay expands surfactants business with Chemlogics buyout
$1.3bn deal brings firm into booming US oil and gas drilling market